Patents by Inventor Gregory O. DUSSOR

Gregory O. DUSSOR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PAR3 mimetic peptides and uses thereof
    Patent number: 11306130
    Abstract: This invention is in the field of medicinal pharmacology. In particular, the invention relates to protease activated receptor type 3 (PAR3) modulating compounds (e.g., mimetic peptides), compositions comprising such modulating compounds, and their use as therapeutics for the treatment of conditions involving PAR3 activity.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: April 19, 2022
    Assignees: ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA, BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Josef Vagner, Scott A. Boitano, Theodore J. Price, Gregory O. Dussor
  • SMALL MOLECULE MODULATORS OF PAR2 AND USES THEREOF
    Publication number: 20210107909
    Abstract: This invention is in the field of medicinal pharmacology. In particular, the invention relates to a new class of small-molecules having a pyrazino-pyrimidine-dione (or related) structure which function as modulators (activators, inhibitors) of protease activated receptor type 2 (PAR2), and their use as therapeutics for the treatment of conditions involving PAR2 activity (e.g., asthma, chronic pain, cancer and/or vascular disorders).
    Type: Application
    Filed: April 9, 2019
    Publication date: April 15, 2021
    Inventors: Scott A. Boitano, Josef Vagner, Theodore J. Price, Gregory O. Dussor
  • RESVERATROL MEDICATION FOR THE TREATMENT OF OCULAR PAIN AND METHOD OF USE THEREOF
    Publication number: 20210046018
    Abstract: The present disclosure provides ophthalmic compositions containing resveratrol. Also provided are methods of using ophthalmic resveratrol compositions to treat acute ocular pain, chronic ocular pain, dry eye disease, and/or photophobia.
    Type: Application
    Filed: August 13, 2020
    Publication date: February 18, 2021
    Applicants: TED'S BRAIN SCIENCE, INC., BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, OREGON HEALTH AND SCIENCE UNIVERSITY
    Inventors: SUE A. AICHER, GREGORY O. DUSSOR, THEODORE J. PRICE, DENNIS I. ROBBINS, DAVID H. HITT, II, DAVID H. HITT, III
  • PAR3 MIMETIC PEPTIDES AND USES THEREOF
    Publication number: 20190119349
    Abstract: This invention is in the field of medicinal pharmacology. In particular, the invention relates to protease activated receptor type 3 (PAR3) modulating compounds (e.g., mimetic peptides), compositions comprising such modulating compounds, and their use as therapeutics for the treatment of conditions involving PAR3 activity.
    Type: Application
    Filed: March 31, 2017
    Publication date: April 25, 2019
    Applicants: Arizona Board of Regents on Behalf of The University of Arizona, Board of Regents, The University of Texas System
    Inventors: Josef VAGNER, Scott A. BOITANO, Theodore J. PRICE, Gregory O. DUSSOR